MedPath

Imaging of High Grade Prostate Cancer

Not Applicable
Terminated
Conditions
Prostatic Carcinoma
Interventions
Device: Imaging
Registration Number
NCT02177526
Lead Sponsor
Ottawa Hospital Research Institute
Brief Summary

Management of prostatic carcinoma varies according to stage of disease. Trans-rectal ultrasound guided biopsy is known to underestimate the degree of tumor due to undersampling and random non-targeted technique. Methods to improve pre-operative tumor localization and grading, including multi-parametric (MP) magnetic resonance imaging (MRI) is an active area of research but requires further validation.

High grade tumors can undergo comedo-type necrosis with malignant calcifications which only occurs in Gleason pattern 5 tumors and which we hypothesize can be reliably detected using computed tomography (CT) and/or MRI.

Detection of malignant calcification within tumor foci will improve the accuracy of localization and grading in prostatic carcinoma.

Detailed Description

High grade (Gleason pattern 5) tumors can undergo comedo-type necrosis producing malignant calcifications which we hypothesize can be reliably detected using computed tomography (CT) and/or MRI. Detection of malignant calcifications in areas of Gleason pattern 5 tumor will improve the accuracy of pre-operative localization and grading in prostatic carcinoma.

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Patients with malignant comedo-type necrosis and calcifications detected with histo-pathology from guided biopsies
  • Patients with biopsy proven Gleason pattern 5 tumor and without comedo-type necrosis associated calcification
Read More
Exclusion Criteria
  • Patients who do not have malignant comedo-type necrosis and calcifications detected with histo-pathology from guided biopsies
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Imaging - CT and MRI examinationsImagingAbdominal and pelvic CT and pelvic MRI imaging will be performed in 30 patients.
Primary Outcome Measures
NameTimeMethod
The number of prostate patients with comedo-type necrosis.up to 4 weeks

Two radiologists will review the MRI and CT examinations separated by a 4 week interval to decrease recall bias. Further, readers will review the 3 additional gradient echo pulse sequences independently at 3 different MRI reading sessions, also separated by 4 weeks, in order to compare the accuracy from each pulse sequence and to reduce recall bias.

Secondary Outcome Measures
NameTimeMethod
The number of other features measured on MRI.up to 4 weeks

Two radiologists will review the MRI and CT examinations separated by a 4 week interval to compare other MRI features and clinical factors between Gleason pattern 5 tumors with and without malignant calcification.

Trial Locations

Locations (1)

Ottawa Hospital (Civic Campus)

🇨🇦

Ottawa, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath